Document is current
Any future updates will be listed below
-
Authors
Kikuta, Masato
Naito, Sei
Osawa, Takahiro
Numakura, Kazuyuki
Narisawa, Takafumi
Takai, Yuki
Yagi, Mayu
Sekine, Yuya
Tokairin, Ojiro
Shinohara, Nobuo
Habuchi, Tomonori
Tsuchiya, Norihiko
- License Information
-
More Information
Article History
Received: 13 November 2024
Accepted: 13 January 2025
First Online: 22 January 2025
Declarations
:
: The Ethics Committee of Hokkaido University approved this study (Approval no, 023–0105). Informed consent was waved by using the opt-out method for this retrospective study.
: Not applicable.
: Sei Naito received honoraria from Pfizer Japan Inc., Merk biopharma Japan Inc., Bristol Meier’s squibb Japan Inc., Ono Pharma, MSD Japan, and Eisai Co. as their sponsored speaker. Takahiro Osawa received honoraria from MSD Japan. Nobuo Shinohara received honoraria from Pfizer, Ono, BMS, MSD, Takeda, Novartis, Eisai, Astra Zeneca, Bayer, Astellas, as their sponsored speaker and research funds from Ono and Takeda. Tomonori Habuchi received honoraria from Astellas, Ono, Janssen, as their sponsored speaker, and research funds from Sysmex and Mochida. Norihiko Tsuchiya received honoraria from Pfizer Japan Inc. Janssen, Novartis, Ono, Bayer, Sanofi, Takeda Pharm, Bristol-Myers Squibb Japan, and Astelas Pharma., as their sponsored speaker and research funds from Pfizer Japan Inc. and Eisai outside the submitted work. The other authors have declared that no conflict of interest exists.
